Seroepidemiological survey of HTLV-I infection among randomized populations of western central African countries
- PMID: 2754613
Seroepidemiological survey of HTLV-I infection among randomized populations of western central African countries
Abstract
Between 1987 and 1988, a survey to determine the distribution of HTLV-I infection was conducted in a representative population of adults, living in southern Chad, Cameroon, and Equatorial Guinea. Populations studied were selected by the cluster sampling technique. Sera were tested for IgG antibodies to HTLV-I by ELISA. ELISA-positive sera were retested by Western blot. The study comprised 2,301 adults, all apparently healthy. Crude prevalence rates range from 0.5 to 11.8%. We found three clearly different areas of HTLV-I seroprevalence rates. An area of low seropositivity in southern Chad and northern Cameroon (0.5-2.0%), an area of moderate seropositivity in the savannah region of Ngaoundere, Cameroon (4.2%) and in Bata, Equatorial Guinea (6.5%), and lastly an area of high seropositivity (8.6-11.8%) in the equatorial forest area of Equatorial Guinea and southern Cameroon. HTLV-I seroprevalence rates increased with age up to 12.6% after 40 years old in the areas of high seropositivity. There was no difference between male and female age-adjusted prevalence rates in all of the areas studied.
Similar articles
-
Epidemiology of HTLV-I in Gabon (Western Equatorial Africa).Int J Cancer. 1988 Nov 15;42(5):687-9. doi: 10.1002/ijc.2910420509. Int J Cancer. 1988. PMID: 3182104
-
Prevalences of HTLV-1 infection and associated risk determinants in an urban population in Guinea-Bissau, West Africa.J Acquir Immune Defic Syndr. 2000 Oct 1;25(2):157-63. doi: 10.1097/00042560-200010010-00010. J Acquir Immune Defic Syndr. 2000. PMID: 11103046
-
Human T lymphotropic virus type I infection in Papua New Guinea: high prevalence among the Hagahai confirmed by western analysis.J Infect Dis. 1990 Sep;162(3):649-54. doi: 10.1093/infdis/162.3.649. J Infect Dis. 1990. PMID: 2387991
-
Seroepidemiology of human T-cell lymphotropic virus type I/II in Benin (West Africa).AIDS Res Hum Retroviruses. 1991 May;7(5):447-51. doi: 10.1089/aid.1991.7.447. AIDS Res Hum Retroviruses. 1991. PMID: 1873079
-
HTLV-1 infection in a population-based cohort of older persons in Guinea-Bissau, West Africa: risk factors and impact on survival.Int J Cancer. 1998 May 4;76(3):293-8. doi: 10.1002/(sici)1097-0215(19980504)76:3<293::aid-ijc1>3.0.co;2-q. Int J Cancer. 1998. PMID: 9579561
Cited by
-
Low degree of human T-cell leukemia/lymphoma virus type I genetic drift in vivo as a means of monitoring viral transmission and movement of ancient human populations.J Virol. 1992 Apr;66(4):2288-95. doi: 10.1128/JVI.66.4.2288-2295.1992. J Virol. 1992. PMID: 1548762 Free PMC article.
-
Geographic distribution, clinical epidemiology and genetic diversity of the human oncogenic retrovirus HTLV-1 in Africa, the world's largest endemic area.Front Immunol. 2023 Feb 3;14:1043600. doi: 10.3389/fimmu.2023.1043600. eCollection 2023. Front Immunol. 2023. PMID: 36817417 Free PMC article. Review.
-
HTLV-I infection in French West Indies: a case-control study.Eur J Epidemiol. 1991 Mar;7(2):175-82. doi: 10.1007/BF00237363. Eur J Epidemiol. 1991. PMID: 2044716
-
Revisiting human T-cell lymphotropic virus types 1 and 2 infections among rural population in Gabon, central Africa thirty years after the first analysis.PLoS Negl Trop Dis. 2018 Oct 25;12(10):e0006833. doi: 10.1371/journal.pntd.0006833. eCollection 2018 Oct. PLoS Negl Trop Dis. 2018. PMID: 30359373 Free PMC article.
-
The epidemiology of HTLV-I infection.Cancer Causes Control. 1991 Jan;2(1):37-52. doi: 10.1007/BF00052359. Cancer Causes Control. 1991. PMID: 1873433 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources